Forward-Looking StatementsThe statements in this press release regarding Cardica's beliefs as to the benefits of Cardica's surgical stapling technology for use with Intuitive Surgical's da Vinci robotic surgical system, as well as the benefits expected to be obtained from the use of the MicroCutter XCHANGE® 30, are "forward-looking statements." There are a number of important factors that could cause results to differ materially from those indicated by these forward-looking statements, including: that the testing to be performed by Cardica at Intuitive's request may not be successful in the six-month feasibility period and development of the 8mm device may not proceed forward; that Cardica may not be successful in its efforts to make the improvements necessary to its enhanced MicroCutter device due to unanticipated technical or other difficulties; risks inherent in obtaining regulatory approvals; as well as other risks detailed from time to time in Cardica's reports filed with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, under the caption "Risk Factors," filed on November 12, 2015. Cardica expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein. You are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.
Contact:Bob NewellVice President, Finance and Chief Financial Officer(650) firstname.lastname@example.org